Pages

Friday, 13 February 2015

Dr. Vasanth K Nalam



Dr. Vasanth K Nalam

DGM-R&D at Suven Life Sciences Ltd.
Previous
  1. Glenmark Research Centre
  2. Lupin Limited. (Research Park),
  3. Unichem Laboratories Ltd
Education
  1. University of Mumbai



Email
vknalam@suven.com












Nalam Vasanth Kumar



Summary

More than 20 years of rich experience in process research for API’s, new chemical entities (NCE’s), custom chemical synthesis (CCS) and contract research & manufacturing services (CRAMS) with reputed pharmaceutical organizations. Good understanding and analytical capabilities over various research areas (Medicinal chemistry & process research) and different business segments like APIs, CCS business.

Role and Responsibilities:

-New synthetic route identification.
-Development of non-infringing synthetic routes for Generic API’s and new chemical entities (NCE) with multiple-step chemistry and Scale-up varies therapeutic areas in a cost effective and environment friendly manner.
-Selection of cost effective suitable synthetic route for commercialization (Process research).
-Process optimization and process robustness demonstration from lab scale to commercial supplies (process development)
-Project leadership roles.
-Managing large team, team building, motivation and drive the team to achieve target.

Professional Experience:

-Complete project management includes heading a group of scientists working in various kind of projects (API, CCS)
-Providing sound technical proposals (chemistry selection, estimation of cost and timelines) & project plans for the custom synthesis and contract research for various clients.
-Responsible to meet the timeline for DMF filings as per business plan.
-Responsible for addressing the regulatory and business queries.
-Responsible for successful scale-up of technology at plant.
-Trouble shooting in Kilo lab/PP/Plant
-Identification of cost contributors and reduction of cost for better project margins and competitive advantage during the execution of projects.

Experience






DGM-R&D

Suven Life Sciences Ltd.
 – Present (6 years plus







Principal Scientist

Glenmark Research Centre
 –  (2 years)Mumbai






Research Scientist

Lupin Limited. (Research Park)
 –  (2 years 11 months)Pune






Group Leader

Unichem Laboratories Ltd
 –  (2 years 3 months)Pharmaceutical Company India - Unichem Laboratories Ltd.







Research Associate

Dr Reddys Labs
 –  (9 years 4 months)


Education





University of Mumbai

Ph.D




Kakatiya University

M.Sc, Chemistry

Kakatiya University

Warangal Area, India


Kakatiya University






Research Publications
Ü Process Research and Development of Melatonin
    C. Prabhakar, N.Vasanth Kumar, M. Ravikanth Reddy, M.R. Sarma and G. Om Reddy.
    Organic Process Research & Development 1999, 3, 155-160
Ü Synthesis and Biological activity of novel Anti-bacterial Quinolones
M R Sarma, N Vasanth Kumar, A S R Prasad, S Eswaraiah, C Prabhakar, G Om Reddy, M Sitaram Kumar, A K Sadhukhan, A Venkateswarlu & K Anji Reddy. Indian Journal of Chemistry. Vol. 40B, 2001, 331-335
Ü Synthesis of some novel   ethyl 6-cyano-7-substituted-5-methyl-2-oxo-2H-pyrano [2, 3-b] pyridine-3-carboxylate derivatives. N Vasanth Kumar & Uday C Mashelker.  Indian J Chem. 45B, 2006, 1770.
Ü Diasteroselective synthesis of some novel Benzopyranopyridine derivatives.
Pradeep K Mohakhud, Sujeet Kumar, N Vasanth Kumar, V. Ravi Kumar, J. Moses Babu, K. Vyas and G Om Reddy, Beilstein Journal of Organic Chemistry 2006, 2:25  
Ü Synthesis of novel 1,2,4-oxadiazole heterocyclic compounds contain 2-H-pyranopyridine-2-one moiety and related compounds. N Vasanth Kumar & Uday C Mashelker.  Indian Journal of Chemistry, 46B, 2007, 216.
Ü Synthesis of novel 3-substituted derivatives of 2H-pyrano[2,3-b]pyridine-2-one moiety 
N Vasanth Kumar & Uday C Mashelkar. Journal of Indian Chemical Society, Vol. 84,October 2007, 1048-1051.
Ü Synthesis of new heterocyclic compounds containing 2H-pyrano-[2,3-b]pyridine-2-one moiety
N Vasanth Kumar & Uday C Mashelkar, Indian Journal of Heterocyclic Chemistry, Vol. 17, July-Sept., 2007, 99-100
Ü Synthesis of some novel 1,2,4-triazolo[4,3-a]-2H-pyrano[3,2-e] pyridine derivatives.
N Vasanth Kumar & Uday C Mashelkar,  Heterocyclic Communications, Vol. 13, No. 4, 2007, 211-214.





Patents & Patent Applications
Ü A novel method for the preparation of aryl piperazinyl heterocyclic compounds.
   Tyagi Om dutt; Srivastava Tushar kumar; Chauhan Yogendra Kumar; Nalam Vasanth Kumar WO
   2006/011157 A2.
Ü Preparation of [2-Methyl-5Phenyl-3-(Piperazin-1-yl Methyl)] Pyrrole Derivatives
     Arora Sudershan Kumar; Sinha Neelima; Jain Sanjay; Upadhayaya Ram Shankar; Tyagi Om Dutt; Nalam
    Vasanth; Chauhan Yogendra Kumar WO 2006/ 109323 A1.
Ü Preparation of (2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)) pyrrole derivatives
    Nalam Vasanth; Chauhan yogendra Kumar; Upadhayaya Ram Shankar; Sinha Neelima; Jain Sanjay;
    Tyagi Om Dutt; Arora Sudershan Kumar AU2006233943

Ü Novel Method for the Preparation of Aryl Piperazinyl-Heterocyclic Compounds

    Tyagi Om D; Srivastava Tushar k ; Chauhan Yogendra K ; Nalam Vasanth K US2007238877
Ü Improved Process for the preparation of 7-amino-3-alkyl-3-cephem-4-carboxylic acid   compounds. Application 961/MUM/2004 published 2007-04-27, filed 2004-09-08
Ü A process for the preparation of novel crystalline form of Ziprasidone base.
    Application 1118/MUM/2004 published 2007-06-08, filed 2004-10-19
Ü A process for the preparation of novel crystalline form of Ziprasidone Hydrochloride Monohydrate Salt.
Application 1119/MUM/2004 published 2007-06-08, filed 2004-10-19.
Ü Improved Process for the manufacture of Ziprasidone.
     Tyagi Om D; Srivastava Tushar k ; Chauhan Yogendra K ; Nalam Vasanth K, Patil Sadanand Nilkanth.
WO2010010566A1.














HIS FAMILY



VASANTH KUMAR


 


 
 




HYDERABAD










No comments:

Post a Comment